A Randomized, Double-blinded, Active Controlled Crossover Clinical Trial to Investigate PK, PD and Safety of GBPD002

Clinical trial NCT05585658 · COMPLETED

Trial details

NCT number: NCT05585658
Sponsor: Globe Biotech Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Natural Blood and Blood Product Toxicity

Start date: 2021-10-16
Primary completion: 2021-11-14
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.